What execs and experts think of the future of drug costs.
Kayt Sukel
Advertisement
Articles by Kayt Sukel
The deal is now official, but the companies have been acting as one for some time.
After last year’s drawn-out flu season, the CDC weighs in on what to expect in 2019-2020
At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.
Specialty pharmacy has reached an “inflection point” with the power to change the entire industry model.
Advertisement
Latest Updated Articles
The Future of Rebates: The Black Swan ScenarioPublished: May 20th 2019 | Updated:
Gottlieb on creating space for opportunity and innovationPublished: July 9th 2019 | Updated:
What Pharmacists Need to Know About the 2019-2020 Flu SeasonPublished: October 10th 2019 | Updated:
Official CVS/Aetna Merger: Greater Convenience, Less Cost ReformPublished: October 17th 2019 | Updated:
Contemplating the Future of List PricesPublished: October 25th 2019 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pneumococcal Conjugate Vaccine Booster Maximizes Protection Against IPD
2
Celebrating the Hard Work Pharmacists Do Everyday
3
American Pharmacists Month: Pharmacies Should Embrace Technology to Drive Profession Forward
4
FDA Approves Roflumilast Cream 0.05% for Atopic Dermatitis in Children 2 to 5
5
